Evidence map›Paper›PMID 40591727›Full record

ArticlePLoS neglected tropical diseases2025

Tracking progress along the WHO Neglected Tropical Diseases Road Map to 2030: A guide to the Gap Assessment Tool (GAT) and results from the 2023-2024 assessment.

Meritxell Donadeu, Theresa W Gyorkos, Olaf Horstick, Patrick Lammie, Upendo J Mwingira, Wyckliff P Omondi, Joanna M Pritchard, Jordan Tappero, YuYen L Chan, Sophie Welsche and 5 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Meritxell DonadeuFaculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Australia.
Theresa W GyorkosDepartment of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Québec, Canada.ORCID 0000-0003-3455-3941
Olaf HorstickHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Patrick LammieNTD Support Center, Task Force for Global Health, Atlanta, Georgia, United States of America.
Upendo J MwingiraRTI International, Durham, North Carolina, United States of America.
Wyckliff P OmondiVector-Borne and Neglected Tropical Diseases Unit (VBNTDU), Ministry of HealthNairobi, Kenya.
Joanna M PritchardNTD Support Center, Task Force for Global Health, Atlanta, Georgia, United States of America.
Jordan TapperoGlobal Health, Bill and Melinda Gates Foundation, Seattle, Washington, United States of America.
YuYen L ChanUnlimit Health, London, United Kingdom.
Sophie WelscheUnlimit Health, London, United Kingdom.
Junerlyn Farah V AguaStrategic Information and Analytics, Global Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.
Serge MadjouStrategic Information and Analytics, Global Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.
Pamela S MbabaziStrategic Information and Analytics, Global Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.
Supriya WarusavithanaEastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt.
Carlos A Torres-VitolasUnlimit Health, London, United Kingdom.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The monitoring and evaluation (M&E) framework for the World Health Organization (WHO) Neglected Tropical Diseases (NTD) road map includes both quantitative and qualitative assessments of progress at key timepoints up to 2030. These assessments provide critical information to improve programmatic action and identify immediate research needs. Quantitative assessments process multi-sourced data on a predefined number of global indicators. Qualitative assessments are based on results obtained from implementing a Gap Assessment Tool (GAT). Informed by paradigm shifts detailed in the road map, a standardised methodology for the GAT has recently been developed. Methods include online public consultations and focus group discussions. GAT outcomes include a visualisation of progress in a 'heat map', a review of the current status of each NTD, and both disease-specific and cross-thematic recommendations for programmatic and research action. These outcomes provide valuable information not only for country NTD programmes, but also for global stakeholders, so that optimal efforts can be made to achieve established NTD road map goals, and ultimately, to reduce the burden of NTDs in at-risk populations. This manuscript provides a summary of the standardised GAT methodology and results from the implementation of the GAT in 2023-2024. Access is provided to the current status of each NTD with respect to four dimensions that were determined as priority in the 2019-2020 gap assessment (Diagnostics, Monitoring and Evaluation, Access & Logistics, and Advocacy & Funding). Results include a timely consensus on the critical and cross-cutting actions needed to improve respective programmatic impact towards eradication, elimination and control of NTDs globally and nationally.

Indexed as

Neglected DiseasesTropical MedicineGlobal HealthHumansWorld Health Organization

Identifiers

PMID40591727
PMCPMC12244624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.